A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
- PMID: 26017687
- PMCID: PMC4458864
- DOI: 10.1038/ncomms8060
A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
Abstract
In observational studies, type-2 diabetes (T2D) is associated with an increased risk of coronary heart disease (CHD), yet interventional trials have shown no clear effect of glucose-lowering on CHD. Confounding may have therefore influenced these observational estimates. Here we use Mendelian randomization to obtain unconfounded estimates of the influence of T2D and fasting glucose (FG) on CHD risk. Using multiple genetic variants associated with T2D and FG, we find that risk of T2D increases CHD risk (odds ratio (OR)=1.11 (1.05-1.17), per unit increase in odds of T2D, P=8.8 × 10(-5); using data from 34,840/114,981 T2D cases/controls and 63,746/130,681 CHD cases/controls). FG in non-diabetic individuals tends to increase CHD risk (OR=1.15 (1.00-1.32), per mmol·per l, P=0.05; 133,010 non-diabetic individuals and 63,746/130,681 CHD cases/controls). These findings provide evidence supporting a causal relationship between T2D and CHD and suggest that long-term trials may be required to discern the effects of T2D therapies on CHD risk.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4458864/bin/ncomms8060-f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4458864/bin/ncomms8060-f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4458864/bin/ncomms8060-f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4458864/bin/ncomms8060-f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4458864/bin/ncomms8060-f5.gif)
Similar articles
-
Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study.BMC Med. 2021 Mar 24;19(1):72. doi: 10.1186/s12916-021-01944-3. BMC Med. 2021. PMID: 33757497 Free PMC article.
-
Genetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease.Circ Res. 2020 May 22;126(11):1526-1548. doi: 10.1161/CIRCRESAHA.119.316065. Epub 2020 May 21. Circ Res. 2020. PMID: 32437307 Free PMC article. Review.
-
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.J Am Heart Assoc. 2017 May 26;6(6):e004918. doi: 10.1161/JAHA.116.004918. J Am Heart Assoc. 2017. PMID: 28550093 Free PMC article. Review.
-
Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.JAMA. 2017 Feb 14;317(6):626-634. doi: 10.1001/jama.2016.21042. JAMA. 2017. PMID: 28196256 Free PMC article.
-
Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.Am J Hum Genet. 2014 Feb 6;94(2):198-208. doi: 10.1016/j.ajhg.2013.12.014. Epub 2014 Jan 23. Am J Hum Genet. 2014. PMID: 24462370 Free PMC article.
Cited by
-
Mendelian randomization studies on coronary artery disease: a systematic review and meta-analysis.Syst Rev. 2024 Jan 16;13(1):29. doi: 10.1186/s13643-023-02442-8. Syst Rev. 2024. PMID: 38225600 Free PMC article.
-
Disentangling Dual Threats: Premature Coronary Artery Disease and Early-Onset Type 2 Diabetes Mellitus in South Asians.J Endocr Soc. 2023 Dec 26;8(1):bvad167. doi: 10.1210/jendso/bvad167. eCollection 2023 Dec 1. J Endocr Soc. 2023. PMID: 38178904 Free PMC article. Review.
-
Bidirectional relationship between type 2 diabetes mellitus and coronary artery disease: Prospective cohort study and genetic analyses.Chin Med J (Engl). 2024 Mar 5;137(5):577-587. doi: 10.1097/CM9.0000000000002894. Epub 2023 Dec 8. Chin Med J (Engl). 2024. PMID: 38062574 Free PMC article.
-
Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study.Cardiovasc Diabetol. 2023 Sep 2;22(1):236. doi: 10.1186/s12933-023-01974-6. Cardiovasc Diabetol. 2023. PMID: 37659996 Free PMC article.
-
Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study.Front Cardiovasc Med. 2023 Jan 9;9:1023355. doi: 10.3389/fcvm.2022.1023355. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36698922 Free PMC article.
References
-
- Gore M. O. & McGuire D. K. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Diab. Vasc. Dis. Res. 6, 53–55 (2009). - PubMed
-
- Coutinho M., Gerstein H. C., Wang Y. & Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22, 233–240 (1999). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical